These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35240084)

  • 1. Multiparametric ultrasound versus multiparametric MRI to diagnose prostate cancer (CADMUS): a prospective, multicentre, paired-cohort, confirmatory study.
    Grey ADR; Scott R; Shah B; Acher P; Liyanage S; Pavlou M; Omar R; Chinegwundoh F; Patki P; Shah TT; Hamid S; Ghei M; Gilbert K; Campbell D; Brew-Graves C; Arumainayagam N; Chapman A; McLeavy L; Karatziou A; Alsaadi Z; Collins T; Freeman A; Eldred-Evans D; Bertoncelli-Tanaka M; Tam H; Ramachandran N; Madaan S; Winkler M; Arya M; Emberton M; Ahmed HU
    Lancet Oncol; 2022 Mar; 23(3):428-438. PubMed ID: 35240084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
    Rouvière O; Puech P; Renard-Penna R; Claudon M; Roy C; Mège-Lechevallier F; Decaussin-Petrucci M; Dubreuil-Chambardel M; Magaud L; Remontet L; Ruffion A; Colombel M; Crouzet S; Schott AM; Lemaitre L; Rabilloud M; Grenier N;
    Lancet Oncol; 2019 Jan; 20(1):100-109. PubMed ID: 30470502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Transrectal Ultrasound Biopsy to Transperineal Template Mapping Biopsies Stratified by Multiparametric Magnetic Resonance Imaging Score in the PROMIS Trial.
    Lovegrove CE; Miah S; El-Shater Bosaily A; Bott S; Brown L; Burns-Cox N; Dudderidge T; Freeman A; Henderson A; Hindley R; Kaplan R; Kirkham A; Oldroyd R; Parker C; Persad R; Punwani S; Rosario D; Shergill I; Winkler M; Emberton M; Ahmed HU
    J Urol; 2020 Jan; 203(1):100-107. PubMed ID: 31335254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study.
    Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M
    Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.
    Ahmed HU; El-Shater Bosaily A; Brown LC; Gabe R; Kaplan R; Parmar MK; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham AP; Oldroyd R; Parker C; Emberton M;
    Lancet; 2017 Feb; 389(10071):815-822. PubMed ID: 28110982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.
    Nordström T; Discacciati A; Bergman M; Clements M; Aly M; Annerstedt M; Glaessgen A; Carlsson S; Jäderling F; Eklund M; Grönberg H;
    Lancet Oncol; 2021 Sep; 22(9):1240-1249. PubMed ID: 34391509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CADMUS trial - Multi-parametric ultrasound targeted biopsies compared to multi-parametric MRI targeted biopsies in the diagnosis of clinically significant prostate cancer.
    Grey A; Scott R; Charman S; van der Meulen J; Frinking P; Acher P; Liyanage S; Madaan S; Constantinescu G; Shah B; Graves CB; Freeman A; Jameson C; Ramachandran N; Emberton M; Arya M; Ahmed HU
    Contemp Clin Trials; 2018 Mar; 66():86-92. PubMed ID: 29108869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Multiparametric MRI and MRI-targeted Biopsy in the Diagnosis of Radiorecurrent Prostate Cancer: An Analysis from the FORECAST Trial.
    Light A; Kanthabalan A; Otieno M; Pavlou M; Omar R; Adeleke S; Giganti F; Brew-Graves C; Williams NR; Emara A; Haroon A; Latifoltojar A; Sidhu H; Freeman A; Orczyk C; Nikapota A; Dudderidge T; Hindley RG; Virdi J; Arya M; Payne H; Mitra AV; Bomanji J; Winkler M; Horan G; Moore CM; Emberton M; Punwani S; Ahmed HU; Shah TT
    Eur Urol; 2024 Jan; 85(1):35-46. PubMed ID: 37778954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.
    Hamid S; Donaldson IA; Hu Y; Rodell R; Villarini B; Bonmati E; Tranter P; Punwani S; Sidhu HS; Willis S; van der Meulen J; Hawkes D; McCartan N; Potyka I; Williams NR; Brew-Graves C; Freeman A; Moore CM; Barratt D; Emberton M; Ahmed HU
    Eur Urol; 2019 May; 75(5):733-740. PubMed ID: 30527787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
    Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
    Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
    Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?
    Abd-Alazeez M; Ahmed HU; Arya M; Allen C; Dikaios N; Freeman A; Emberton M; Kirkham A
    Urol Oncol; 2014 Aug; 32(6):741-7. PubMed ID: 24981993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
    van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
    Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS
    JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.
    Norris JM; Carmona Echeverria LM; Bott SRJ; Brown LC; Burns-Cox N; Dudderidge T; El-Shater Bosaily A; Frangou E; Freeman A; Ghei M; Henderson A; Hindley RG; Kaplan RS; Kirkham A; Oldroyd R; Parker C; Persad R; Punwani S; Rosario DJ; Shergill IS; Stavrinides V; Winkler M; Whitaker HC; Ahmed HU; Emberton M
    Eur Urol; 2020 Aug; 78(2):163-170. PubMed ID: 32370911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography: The IP1-PROSTAGRAM Study.
    Eldred-Evans D; Burak P; Connor MJ; Day E; Evans M; Fiorentino F; Gammon M; Hosking-Jervis F; Klimowska-Nassar N; McGuire W; Padhani AR; Prevost AT; Price D; Sokhi H; Tam H; Winkler M; Ahmed HU
    JAMA Oncol; 2021 Mar; 7(3):395-402. PubMed ID: 33570542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
    Arsov C; Rabenalt R; Blondin D; Quentin M; Hiester A; Godehardt E; Gabbert HE; Becker N; Antoch G; Albers P; Schimmöller L
    Eur Urol; 2015 Oct; 68(4):713-20. PubMed ID: 26116294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level--can it rule out clinically significant prostate cancer?
    Abd-Alazeez M; Ahmed HU; Arya M; Charman SC; Anastasiadis E; Freeman A; Emberton M; Kirkham A
    Urol Oncol; 2014 Jan; 32(1):45.e17-22. PubMed ID: 24055430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
    Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
    BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.